2α-Ferrocenylmethyl-DHT
2α-Ferrocenylmethyl-DHT is a dihydrotestosterone-derived ferrocene-steroid conjugate. 2α-Ferrocenylmethyl-DHT inhibits the growth of various cancer cells. 2α-Ferrocenylmethyl-DHT induces S-phase cell cycle arrest in ovarian cancer cells, elevates intracellular iron levels, triggers ROS-dependent cell death, and disrupts the integrity of multicellular tumor spheroids of ovarian cancer cells. 2α-Ferrocenylmethyl-DHT can be used in the research of prostate cancer and ovarian cancer.
For research use only. We do not sell to patients.
- Formula: C30H40FeO
- Molecular Weight:472.48
-
Storage:
Please store the product under the recommended conditions in the Certificate of Analysis.
Biological Activity
Description
In Vitro
2α-Ferrocenylmethyl-DHT (Compound 2) (3.12-50 μM; 72 h) potently inhibits the growth of OVCAR-3 (IC50 = 2.8 μM), PC-3 (IC50 = 16.8 μM), LNCaP (IC50 = 16 μM) cancer cells and non-malignant MRC-5 fibroblasts (IC50 = 8.5 μM), and exhibits moderate tumor selectivity toward OVCAR-3 cells[1].
2α-Ferrocenylmethyl-DHT (2.8 μM; 48 h, 72 h) induces time-dependent S-phase arrest in OVCAR-3 cells, with extremely low accumulation of Sub-G1 phase cells[1].
Treatment with 2α-Ferrocenylmethyl-DHT (50 μM; 24 h) increases intracellular iron levels in OVCAR-3 cells by 21-fold[1].
2α-Ferrocenylmethyl-DHT (0.3-30 μM; 72 h) induces ROS-dependent, caspase-independent cell death in OVCAR-3 cells[1].
2α-Ferrocenylmethyl-DHT (3.12-50 μM; 72 h) disrupts the integrity and inhibits the growth of OVCAR-3 multicellular tumor spheroids, with an IC50 of 14 μM[1].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only. Further protocols information, click here.
-
Cell Line:human prostate adenocarcinoma PC-3 cells, LNCaP cells, ovarian adenocarcinoma OVCAR-3 cells, non-malignant MRC-5 fetal lung fibroblasts
-
Concentration:3.12, 6.25, 12.5, 25, 50 μM
-
Incubation Time:72 h
-
Result:Inhibited PC-3 cell growth with an IC50 of 16.8 μM.
Inhibited LNCaP cell growth with an IC50 of 16 μM.
Inhibited OVCAR-3 cell growth with an IC50 of 2.8 μM.
Inhibited MRC-5 cell growth with an IC50 of 8.5 μM.
Achieved a selectivity index of 3.03 for OVCAR-3 cells relative to MRC-5 cells.
-
Cell Line:human ovarian adenocarcinoma OVCAR-3 cells
-
Concentration:2.8 μM
-
Incubation Time:48 h; 72 h
-
Result:Increased S-phase population to 24.1=% after 72 h, compared to 10=% in untreated controls.
Reduced G1 phase population and elevated G2/M phase population after 72 h.
Increased Sub-G1 fraction to 9.3% after 72 h.
-
Cell Line:3D multicellular tumor spheroids (MCTSs) of human ovarian adenocarcinoma OVCAR-3 cells
-
Concentration:3.12, 6.25, 12.5, 25, 50 μM
-
Incubation Time:72 h
-
Result:Inhibited OVCAR-3 MCTS growth with an IC50 of 14 μM.
Induced weakening of intercellular contacts and loss of spheroid compactness starting at 6.25 μM.
Caused complete loss of spheroid architecture at 50 μM.
Chemical Information
-
Molecular Weight 472.48
-
Formula C30H40FeO
-
SMILES
C[C@]1(C/2)[C@](CC[C@]3([H])[C@]1([H])CC[C@@]4(C)[C@@]3([H])CC[C@@H]4O)([H])CCC2=C\c5cccc5.[][Fe][].c6cccc6
-
Shipping
Room temperature in continental US; may vary elsewhere.
-
Storage
Please store the product under the recommended conditions in the Certificate of Analysis.
Protocols
-
Flow cytometric DNA-content cell-cycle staining
Flow cytometric DNA-content cell-cycle staining measures the fluorescence intensity of DNA-bound fluorochromes in single cells or nuclei to estimate DNA content distributions, allowing assignment of populations to G0/G1, S, and G2/M phases by DNA histogram deconvolution. Propidium iodide (PI) intercalates into DNA, and PI fluorescence is proportional to cellular DNA content when staining is performed under conditions that make DNA accessible and minimize non-DNA signal. Cells with G2/M DNA content are expected to show approximately twice the fluorescence intensity of G0/G1 cells, while S-phase cells occupy intermediate fluorescence values. PI-based DNA-content analysis can also detect cells with fractional DNA content, often reported as sub-G1, when DNA fragmentation and extraction during staining reduce retained DNA signal in apoptotic cells. DAPI is an alternative DNA fluorochrome for univariate DNA-content analysis, while bivariate approaches combining DNA content with proliferation
-
Cell Cytotoxicity Assay
Cytotoxicity assays are usually based on the assessment of cell membrane damage, which can also be indirectly detected by measuring cell viability. Detection methods include MTT assay, CKK-8 assay, LDH assay and ATP assay, etc.
-
Mammalian live/dead viability and cytotoxicity staining
Live/dead viability and cytotoxicity staining assays are based on the simultaneous detection of intracellular esterase activity in metabolically active (viable) cells and membrane integrity loss in non-viable cells. In commonly used dual-staining approaches, membrane-permeant fluorogenic substrates are converted by intracellular esterases into fluorescent products in live cells, while impermeant DNA-binding dyes selectively enter cells with compromised plasma membranes and label nucleic acids in dead or dying cells, enabling discrimination between viable and non-viable populations by fluorescence microscopy or flow cytometry.
-
BrdU Incorporation Assay
Bromodeoxyuridine (BrdU) incorporation assay is based on the principle that BrdU, a thymidine analog, is incorporated into newly synthesized DNA during the S phase of the cell cycle, thereby serving as a marker of DNA replication and cellular proliferation. Incorporated BrdU can be detected using anti-BrdU antibodies following DNA denaturation, enabling visualization or quantification of proliferating cells through immunochemical detection methods such as immunofluorescence or immunohistochemistry.
-
ROS/oxidative-stress fluorescent staining
ROS/oxidative-stress fluorescent staining uses cell-permeant fluorogenic probes that become fluorescent after oxidation inside cells or tissues; commonly used examples include DCFH-DA/DCFDA for broad cellular oxidant detection, DHE for superoxide-related signal detection, MitoSOX for mitochondrial superoxide-related signal detection, and CellROX probes for oxidative-stress-associated fluorescence readouts. The assay detects probe oxidation rather than a single ROS species unless the probe and analysis method have been chemically validated for that species. DCFH-DA enters cells, is deacetylated by intracellular esterases to DCFH, and produces fluorescent DCF after oxidation, so the readout is used as an operational measure of total cellular oxidative stress rather than a species-specific ROS measurement. DHE and MitoSOX can report superoxide-related oxidation, but red fluorescence alone can include non-specific ethidium-like oxidation products; HPLC or optimized spectral approaches are
-
Apoptosis Solutions
Apoptosis is a regulated, generally non-lytic cell-death pathway that removes unwanted, damaged, infected, or abnormal cells through coordinated morphological changes, caspase activation, DNA fragmentation, and membrane remodeling. The intrinsic apoptosis pathway is controlled mainly by mitochondrial outer membrane permeabilization, BCL-2 family proteins, cytochrome c release, apoptosome formation, caspase-9 activation, and downstream executioner caspase-3/7 activation. The extrinsic apoptosis pathway is initiated by death receptors such as Fas, TNFR, and TRAIL receptors, which recruit adaptor proteins and activate caspase-8 before engaging executioner caspases or mitochondrial amplification through BID cleavage. Apoptosis is linked to many phenotypes, including cancer cell killing, tissue homeostasis, immune regulation, neurodegeneration, infection response, and treatment-induced cytotoxicity; unresolved questions include how apoptosis interacts with necroptosis, pyroptosis, ferroptos
-
Protocol for Cell Cycle
Cell-cycle analysis by flow cytometry measures DNA content in single cells to estimate the fraction of cells in G0/G1, S, and G2/M phases. Propidium iodide intercalates into DNA, and after RNA removal with RNase, fluorescence intensity reflects cellular DNA content: 2N cells are assigned to G0/G1, cells between 2N and 4N to S phase, and 4N cells to G2/M. DNA-content analysis alone cannot reliably separate G0 from G1 or G2 from M. Ki-67 can distinguish quiescent G0 cells from cycling cells, EdU or BrdU incorporation marks active DNA synthesis in S phase, and phospho-histone H3 staining identifies mitotic cells within the 4N population.
Purity & Documentation
References
Calculators
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)